Cargando…
Evaluation of the Inhibitory Effects of Bavachinin and Bavachin on Human Monoamine Oxidases A and B
Monoamine oxidase B inhibitors (MAO-BIs) are used in the early management of Parkinson's disease (PD). Long-term suspected side effects of MAO-B classical inhibitors established the need for safer alternative therapeutic agents. In our study, the flavanone bavachinin (BNN) and its analog bavach...
Autores principales: | Zarmouh, Najla O., Mazzio, Elizabeth A., Elshami, Faisel M., Messeha, Samia S., Eyunni, Suresh V. K., Soliman, Karam F. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629031/ https://www.ncbi.nlm.nih.gov/pubmed/26557867 http://dx.doi.org/10.1155/2015/852194 |
Ejemplares similares
-
Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors
por: Zarmouh, Najla O., et al.
Publicado: (2016) -
Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor
por: Zarmouh, Najla O., et al.
Publicado: (2016) -
The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor
por: Zarmouh, Najla O., et al.
Publicado: (2017) -
1,2,3,4,6-Penta-O-galloylglucose within Galla Chinensis Inhibits Human LDH-A and Attenuates Cell Proliferation in MDA-MB-231 Breast Cancer Cells
por: Deiab, Shihab, et al.
Publicado: (2015) -
Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer
por: Messeha, Samia S., et al.
Publicado: (2021)